{"id":792,"date":"2026-09-01T17:35:05","date_gmt":"2026-09-01T17:35:05","guid":{"rendered":"https:\/\/nhdbio.com\/resources\/melanotan-ii-cyclic-peptide-identity-quality-guide\/"},"modified":"2026-09-08T07:30:41","modified_gmt":"2026-09-08T07:30:41","slug":"melanotan-ii-cyclic-peptide-identity-quality-guide","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/es\/melanotan-ii-cyclic-peptide-identity-quality-guide\/","title":{"rendered":"Gu\u00eda de identidad Melanotan II: secuencia c\u00edclica y riesgos de calidad"},"content":{"rendered":"

Melanotan II is a cyclic heptapeptide analogue of \u03b1-MSH. Its lactam ring, D-phenylalanine and terminal modifications are identity-defining.<\/p>

Evidence at a glance<\/h2>
  • PubChem lists formula C50H69N15O9, molecular weight 1024.2 g\/mol and CID 92432.<\/li>
  • The condensed sequence is Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp-Lys(1)-NH2, with a side-chain lactam bridge.<\/li>
  • Regulator testing of online products found large between-bottle content differences, so appearance and label strength are not identity evidence.<\/li><\/ul><\/div><\/div>
    \"Documentary
    AI-generated editorial illustration illustrating an analytical workflow. It does not depict a supplied product, released lot, approved formulation or assay result.<\/figcaption><\/figure>

    Identity record<\/h2>

    A linear peptide with the same residue list is not Melanotan II. Ring closure changes mass, conformation and chromatographic behavior; stereochemistry at D-Phe also needs to match the reference.<\/p>

    Sequence<\/strong>Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2<\/span><\/div>
    Formula and mass<\/strong>C50H69N15O9; 1024.2 g\/mol<\/span><\/div>
    PubChem<\/strong>CID 92432<\/span><\/div>
    Critical features<\/strong>N-acetylation, norleucine, D-Phe, lactam closure and C-terminal amide<\/span><\/div>
    Core tests<\/strong>Intact mass, peptide mapping, ring\/sequence evidence, purity, content and aggregation<\/span><\/div><\/div><\/div>

    Analytical and evidence boundary<\/h2>

    Peptide-related impurities and aggregation can create immunogenicity concerns for some routes. FDA\u2019s compounding safety page explicitly identifies these concerns for Melanotan II.<\/p>

    Do not use \u201ctanning peptide\u201d as if it were an approved indication. The FDA record describes Melanotan II as an unapproved new drug, and research-use copy should not provide consumer administration guidance.<\/p>

    Editorial rule<\/h2>

    State the exact material, form, model or population and endpoint supported by the cited record. Do not convert mechanistic plausibility, an animal result, an official finished-drug label or an analytical test into a claim about an unrelated catalog lot.<\/p>","protected":false},"excerpt":{"rendered":"

    Melanotan II es un an\u00e1logo heptap\u00e9ptido c\u00edclico de \u03b1-MSH. Su anillo lactama, D-fenilalanina y modificaciones terminales definen la identidad.<\/p>","protected":false},"author":1,"featured_media":776,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"350","pim_article_type":"Evidence and material-quality guide","pim_evidence_level":"PubChem identity, primary human exposure and regulator-tested product data","pim_reviewer":"Site evidence editorial team","pim_reviewed_date":"2026-09-02","pim_editorial_note":"Source-checked on 2026-09-02. Null results, sample size, model\/population limits and regulatory scope are retained. This is not medical advice, a customer case or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"Primary and official sources, numerical results, null findings, limitations, product-evidence boundary and image disclosure checked for batch 4.","pim_creation_method":"This article discusses the source records listed below, with the study models and limitations stated alongside the findings. AI-assisted drafting and image generation were used. The reference list identifies the records behind this article; it is not an independent peer review or verification of a supplied catalog lot.","pim_sources":"[{\"title\":\"Melanotan II pilot phase I study\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/8637402\/\",\"note\":\"Three-person single-blind pilot; PMID 8637402.\"},{\"title\":\"Melanotan II systemic toxicity and rhabdomyolysis\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23121206\/\",\"note\":\"Mass-spectrometry-confirmed case report; PMID 23121206.\"},{\"title\":\"TGA finds inconsistent Melanotan II content\",\"url\":\"https:\/\/www.tga.gov.au\/safety\/safety-monitoring-and-information\/safety-alerts\/melanotan-ii-tanning-peptide-products-found-be-inconsistently-dosed\",\"note\":\"Official August 2026 laboratory-testing safety alert.\"},{\"title\":\"FDA Melanotan II enforcement record\",\"url\":\"https:\/\/www.fda.gov\/regulatory-information\/electronic-reading-room\/notice-opportunity-hearing-nooh-manookian-edward-8516\",\"note\":\"Official record describing Melanotan II as an unapproved new drug.\"},{\"title\":\"PubChem Melanotan II record\",\"url\":\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/melanotan-II\",\"note\":\"Cyclic sequence, formula and molecular weight; CID 92432.\"}]","footnotes":""},"categories":[20],"tags":[],"class_list":["post-792","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-evidence-quality-guides"],"yoast_head":"\nMelanotan II Identity Guide: Cyclic Sequence and Quality Risks<\/title>\n<meta name=\"description\" content=\"Melanotan II is a cyclic heptapeptide analogue of \u03b1-MSH. Its lactam ring, D-phenylalanine and terminal modifications are identity-defining.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/es\/melanotan-ii-cyclic-peptide-identity-quality-guide\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Melanotan II Identity Guide: Cyclic Sequence and Quality Risks\" \/>\n<meta property=\"og:description\" content=\"Melanotan II is a cyclic heptapeptide analogue of \u03b1-MSH. Its lactam ring, D-phenylalanine and terminal modifications are identity-defining.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/es\/melanotan-ii-cyclic-peptide-identity-quality-guide\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-01T17:35:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-08T07:30:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-quality.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1672\" \/>\n\t<meta property=\"og:image:height\" content=\"941\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-cyclic-peptide-identity-quality-guide\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-cyclic-peptide-identity-quality-guide\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"Melanotan II Identity Guide: Cyclic Sequence and Quality Risks\",\"datePublished\":\"2026-09-01T17:35:05+00:00\",\"dateModified\":\"2026-09-08T07:30:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-cyclic-peptide-identity-quality-guide\\\/\"},\"wordCount\":265,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-cyclic-peptide-identity-quality-guide\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/melanotan-ii-quality.webp\",\"articleSection\":[\"Evidence & Quality Guides\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-cyclic-peptide-identity-quality-guide\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-cyclic-peptide-identity-quality-guide\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-cyclic-peptide-identity-quality-guide\\\/\",\"name\":\"Melanotan II Identity Guide: Cyclic Sequence and Quality Risks\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-cyclic-peptide-identity-quality-guide\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-cyclic-peptide-identity-quality-guide\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/melanotan-ii-quality.webp\",\"datePublished\":\"2026-09-01T17:35:05+00:00\",\"dateModified\":\"2026-09-08T07:30:41+00:00\",\"description\":\"Melanotan II is a cyclic heptapeptide analogue of \u03b1-MSH. Its lactam ring, D-phenylalanine and terminal modifications are identity-defining.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-cyclic-peptide-identity-quality-guide\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-cyclic-peptide-identity-quality-guide\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-cyclic-peptide-identity-quality-guide\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/melanotan-ii-quality.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/melanotan-ii-quality.webp\",\"width\":1672,\"height\":941,\"caption\":\"AI-generated illustration: cyclic-peptide quality-control bench\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-cyclic-peptide-identity-quality-guide\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Melanotan II Identity Guide: Cyclic Sequence and Quality Risks\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/es\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Gu\u00eda de identidad Melanotan II: secuencia c\u00edclica y riesgos de calidad","description":"Melanotan II es un an\u00e1logo heptap\u00e9ptido c\u00edclico de \u03b1-MSH. Su anillo lactama, D-fenilalanina y modificaciones terminales definen la identidad.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/es\/melanotan-ii-cyclic-peptide-identity-quality-guide\/","og_locale":"es_ES","og_type":"article","og_title":"Melanotan II Identity Guide: Cyclic Sequence and Quality Risks","og_description":"Melanotan II is a cyclic heptapeptide analogue of \u03b1-MSH. Its lactam ring, D-phenylalanine and terminal modifications are identity-defining.","og_url":"https:\/\/nhdbio.com\/es\/melanotan-ii-cyclic-peptide-identity-quality-guide\/","og_site_name":"NHD","article_published_time":"2026-09-01T17:35:05+00:00","article_modified_time":"2026-09-08T07:30:41+00:00","og_image":[{"width":1672,"height":941,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-quality.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Escrito por":"NHD Technical Team","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/melanotan-ii-cyclic-peptide-identity-quality-guide\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/melanotan-ii-cyclic-peptide-identity-quality-guide\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"Melanotan II Identity Guide: Cyclic Sequence and Quality Risks","datePublished":"2026-09-01T17:35:05+00:00","dateModified":"2026-09-08T07:30:41+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/melanotan-ii-cyclic-peptide-identity-quality-guide\/"},"wordCount":265,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/melanotan-ii-cyclic-peptide-identity-quality-guide\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-quality.webp","articleSection":["Evidence & Quality Guides"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/melanotan-ii-cyclic-peptide-identity-quality-guide\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/melanotan-ii-cyclic-peptide-identity-quality-guide\/","url":"https:\/\/nhdbio.com\/melanotan-ii-cyclic-peptide-identity-quality-guide\/","name":"Gu\u00eda de identidad Melanotan II: secuencia c\u00edclica y riesgos de calidad","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/melanotan-ii-cyclic-peptide-identity-quality-guide\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/melanotan-ii-cyclic-peptide-identity-quality-guide\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-quality.webp","datePublished":"2026-09-01T17:35:05+00:00","dateModified":"2026-09-08T07:30:41+00:00","description":"Melanotan II es un an\u00e1logo heptap\u00e9ptido c\u00edclico de \u03b1-MSH. Su anillo lactama, D-fenilalanina y modificaciones terminales definen la identidad.","breadcrumb":{"@id":"https:\/\/nhdbio.com\/melanotan-ii-cyclic-peptide-identity-quality-guide\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/melanotan-ii-cyclic-peptide-identity-quality-guide\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/nhdbio.com\/melanotan-ii-cyclic-peptide-identity-quality-guide\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-quality.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-quality.webp","width":1672,"height":941,"caption":"AI-generated illustration: cyclic-peptide quality-control bench"},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/melanotan-ii-cyclic-peptide-identity-quality-guide\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"Melanotan II Identity Guide: Cyclic Sequence and Quality Risks"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Materias primas pept\u00eddicas y s\u00edntesis personalizada","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"Equipo t\u00e9cnico de NHD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"El equipo t\u00e9cnico de NHD mantiene documentaci\u00f3n del cat\u00e1logo de uso de investigaci\u00f3n y res\u00famenes de evidencia. Los art\u00edculos revisados \u200b\u200benlazan con art\u00edculos revisados \u200b\u200bpor pares, registros de ensayos y registros regulatorios, conservan hallazgos nulos y limitaciones de estudios, y distinguen las intervenciones publicadas de los materiales del cat\u00e1logo. Se puede utilizar dibujo asistido por AI para la estructura; los enlaces de fuentes y los l\u00edmites de las pruebas permanecen visibles. Este trabajo no es una revisi\u00f3n por pares independiente ni un consejo m\u00e9dico.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/es\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/792","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/comments?post=792"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/792\/revisions"}],"predecessor-version":[{"id":1195,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/792\/revisions\/1195"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/media\/776"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/media?parent=792"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/categories?post=792"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/tags?post=792"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}